SciTransfer
Organization

DEUTSCHES PRIMATENZENTRUM GMBH

German primate research center specializing in neuroscience, brain-machine interfaces, and pre-clinical primate models for translational biomedicine.

Research institutehealthDE
H2020 projects
9
As coordinator
3
Total EC funding
€5.4M
Unique partners
35
What they do

Their core work

The German Primate Center (DPZ) is one of Europe's leading primate research institutes, conducting fundamental and translational research using non-human primate models. Their core work spans neuroscience — understanding brain networks, perception, and neural control of movement — as well as comparative psychology and behavioral biology. They also contribute primate models to biomedical research, including cardiovascular regeneration and diabetes-related coronary disease, serving as a critical bridge between basic science and pre-clinical applications.

Core expertise

What they specialise in

Primate neuroscience and brain-machine interfacesprimary
4 projects

Projects Plan4Act, VarPL, In2PrimateBrains, and B-CRATOS all center on primate brain networks, neural communication, and translating brain signals into device control.

Comparative and developmental psychologysecondary
1 project

HelpSeeking (coordinated by DPZ) investigates help-seeking behavior across chimpanzees and children, combining evolutionary and developmental perspectives.

Cardiovascular regeneration and disease modelsemerging
2 projects

REANIMA focuses on cardiac regenerative therapies and DIAMONDCOR on diabetes-linked coronary disease, both using primate models for pre-clinical validation.

Primate immunogenetics and hybrid biologysecondary
1 project

HybridImmunogenetics (coordinated by DPZ) studied immune profiles in wild hybrid marmosets, linking genetics to disease susceptibility.

Perceptual learning and visual neurosciencesecondary
2 projects

DecodePL and VarPL both investigate mechanisms of perceptual learning using combined human-macaque fMRI and electrophysiology approaches.

Evolution & trajectory

How they've shifted over time

Early focus
Visual neuroscience and perceptual learning
Recent focus
Translational biomedicine and neural interfaces

DPZ's early H2020 involvement (2017–2019) focused heavily on visual neuroscience and perceptual learning, using macaque models alongside human subjects to study how the brain processes and adapts to visual information. From 2020 onward, their portfolio broadened significantly into cardiovascular regeneration (REANIMA, DIAMONDCOR), comparative psychology (HelpSeeking), and applied neural interfaces (B-CRATOS). This shift suggests a deliberate move from fundamental perception research toward both translational biomedical applications and cross-species behavioral science.

DPZ is expanding from fundamental primate neuroscience into applied domains — brain-machine interfaces for medical devices and primate models for cardiac therapy — making them increasingly relevant for translational health consortia.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European15 countries collaborated

DPZ operates primarily as a specialist partner (6 of 9 projects), bringing primate models and neuroscience infrastructure to larger consortia, while coordinating smaller, focused projects where they hold domain leadership (3 coordinated projects). With 35 unique partners across 15 countries, they maintain a broad but non-repetitive network, suggesting they are sought after by diverse groups rather than locked into a fixed cluster. This makes them accessible for new collaborations — they are used to integrating into unfamiliar consortia.

DPZ has collaborated with 35 distinct partners across 15 countries, indicating a well-distributed European network. Their partnerships span universities, hospitals, and technology developers, reflecting the translational nature of their primate research facility.

Why partner with them

What sets them apart

DPZ is one of very few European research centers that can provide non-human primate models, neuroscience infrastructure, and ethical expertise under one roof — a combination that is both rare and tightly regulated. For any consortium needing pre-clinical primate validation, whether in neurotechnology, cardiac therapy, or behavioral science, DPZ is often the only realistic partner in Germany. Their dual capacity in fundamental brain research and translational medicine makes them a natural bridge between academic discovery and clinical application.

Notable projects

Highlights from their portfolio

  • DIAMONDCOR
    Largest single grant (EUR 1.23M) and coordinated by DPZ — an ERC-funded project linking diabetes to coronary disease, showing DPZ's ambition beyond neuroscience.
  • B-CRATOS
    Directly targets wireless brain-computer interfaces as medical devices, representing DPZ's most applied and commercially relevant project in neural technology.
  • HelpSeeking
    Coordinated by DPZ, this project uniquely compares chimpanzee and human child behavior, showcasing their strength in cross-species comparative psychology.
Cross-sector capabilities
Digital health and neurotechnologyMedical devices and brain-computer interfacesBehavioral science and developmental psychologyPre-clinical validation for pharmaceutical and gene therapy
Analysis note: Several early projects (DecodePL, Plan4Act, DIAMONDCOR, HybridImmunogenetics) lack keyword data, so expertise mapping for 2017-2018 relies partly on project titles. The profile is otherwise well-supported by 9 projects with clear thematic coherence.